62
Views
38
CrossRef citations to date
0
Altmetric
Research Article

THE MOUSE EAR MODEL OF CUTANEOUS SULFUR MUSTARD INJURY

Pages 381-397 | Published online: 30 Sep 2008

REFERENCES

  • Momeni AZ, Enshaeih S, Meghdadi M, Amindjavaheri M. Skin manifestations of mustard gas. Arch Dermatol. 1992;128:775–780.
  • Borak J, Sidell FR. Agents of chemical warfare: sulfur mustard. Ann Emerg Med. 1992;21:303–308.
  • Smith WJ, Dunn MA. Medical defense against blistering chemical warfare agents. Arch Dermatol. 1991;127:1207–1213.
  • Petrali JP, Oglesby-M egee S. Toxicity of mustard gas skin lesions. Microsc Res Tech. 1997;37:221–228.
  • Papirmeister B, Feister AJ, Robinson SI, Ford RD. Medical Defense Against Mustard Gas: Toxic Mechanism s and Pharm acological Implications. Boca Raton, FL: CRC; 1991.
  • Barranco VP. Mustard gas and the dermatologist. Int J Dermatol. 1991;30;684-686.
  • Cowan FM, Broomfield CA. Putative roles of inflammation in the derma- top athology of sulfur mustard. Cell Biol Toxicol. 1993;9:201–213.
  • Monteiro-Riviere NA, Inman AO. Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin. Microsc Res Tech. 1997;37:229–241.
  • Sailstad DM, Tepper JS, Doerfler DL, Selgrade MJ. Evaluation of several variations of the mouse ear swelling test (MEST) for detection of weak and moderate contact sensitizers. Toxicol Methods. 1993;3:169–182.
  • Gabor M, Razga Z. Development and inhibition of mouse ear edema induced with capsaicin. Agents Actions. 1992;36;83-86.
  • Patrick E, Burkhalter A, Maibach H. Mouse ear assays as models for studying mechanisms of chemically induced irritation. Models Dermatol. 1 987;3:86–92.
  • Inoue H, Nagata N, Koshihara Y. Involvement of tachykinin receptors in oedem a form ation and plasm a extravasation induced by substance P, neu- rokinin A, and neurokinin B in mouse ear. Inflamm Res. 1996;45:316–323.
  • Kotyuk B, Raychaudhuri A, DiPasquale G. Effect of anti-inflammatory compounds on edema formation and myeloperoxidase activity in the arachidonic acid-induced ear model in the mouse. Agents Actions. 1993;39:C46–C48.
  • Crummey A, Harper GP, Boyle EA, Mangan FR. Inhibition of arachdonic acid-induced ear oedema as a model for assessing topical antiinflammatory compounds. Agents Actions. 1987;20:69–76.
  • Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agen ts Actions. 1985;17:197–204.
  • Brinkley FB, Mershon MM, Yaverbaum S, Doxzon BF, Wade J V. The mouse ear model as an in vivo bioassay for the assessent of topical mustard (HD) injury. In: Proceedings of the 1989 Medical Defense B ioscien ce Review, USAMRICD, Aberdeen Proving Ground, Maryland, 15±17 August 1989, pp 595-602, AD B1395 50.
  • Brinkley FB, Maitland GF, Hackley BE Jr. Validation of the mouse ear model as an in vivo bio-assay for the assessment of topical mustard (H D) injury. Technical Report AD A296752.
  • Smith KJ, Casillas R, Graham J, Skelton HG, Stemler F, Hackley BE. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. J Dermatol Sci. 1997;14:126-1 35.
  • Zlotogorski A, Goldenhersh M, Shafran A. A model for quantitative measurement of sulfur mustard skin lesions in the rabbit ear. Toxicology. 1997;120:105–110.
  • Brown RF, Rice P. H istopathological changes in Yucatan minipig skin following challenge with sulphur mustard: a sequential study of the first 24 hours following challenge. Int J Exp Pathol. 1997;78:9–20.
  • Lindsay CD, Rice P. Assessment of the biochemical effects of percutaneous exposure of sulphur mustard in an in vitro human skin system. Hum Exp Toxicol. 1996;15:237–244.
  • Mol MA, De Vries R, and Kluivers AW. Effects of nicotinamide on biochemical changes and microblistering induced by sulfur mustard in human skin organ cultures. Toxicol Appl Pharm a col. 1991;107:439–449.
  • Monteiro-Riviere NA, King JR, Riviere JE. Mustard-induced vesication in isolated perfused skin: biochemical, physiological, and morphological studies. In Proceedings of the 1991 Medical Defense Bioscience Review, USAMRICD, Aberdeen Proving Ground, Maryland, 7-8 August 1991, pp 31-40, AD B 158 588.
  • Marlow DD, Mershon MM, Mitcheltree LW, Petrali J P, Jaax GP. Sulfur mustard-induced skin injury in hairless guinea pigs.J Toxicol Cut Ocular Toxicol. 1990;9:179–192.
  • Petrali JP, Oglesby SB, Mills KR. Ultra structural correlates of sulfur mustard toxicity. J Toxicol Cut Ocular Toxicol. 1990;9:193–214.
  • Mitcheltree LW, Mershon MM, Wall HG, Pulliam JD. Microblister formation in vesicant-exposed pig skin. J Toxicol Cut Ocular Toxicol. 1989;8:309–319.
  • Papirm eister B, Gross CL, Petrali J P, H ixson CJ. Pathology produced by sulfur mustard in human skin grafts on athymic nude mice, I: gross and light microscopic changes. J Toxicol Cut Ocular Toxicol. 1984;3:371–391.
  • McAdams AJ. A study of mustard vesication. J Invest Dermatol. 1956;26:317–326.
  • Gad SC. The mouse ear swelling test (MEST) in the 1990s. Toxicology. 1994;93:33–46.
  • Patrick E, Maibach HI, Burkhalter A. Mechanism of chemically induced skin irritation. Toxicol Appl Pharm a col. 1985;81:476–490.
  • Dacre JC, Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol Rev. 1996;48:289–326.
  • Casillas RP, Santai CT, France J. Cytokines as potential biomarkers of cutaneous vesicant injury. Fed Am Soc Exp Biol. 1996;10:A421.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.